At the forefront of podiatric innovation, Robert Kelemen, DPM has spent decades optimizing patient care at his practice. After witnessing the limitations of traditional approaches to foot and ankle care, often leaving patients with unsatisfactory results, he was determined to find better solutions to managing podiatric conditions.
On his journey to offer new solutions, Dr. Kelemen’s discovered Multiwave Locked System® (MLS) Laser Therapy. MLS Laser Therapy utilizes near-infrared light to stimulate biological processes at the cellular level, thereby accelerating the body’s natural healing processes and reducing pain and inflammation.
Initially skeptical, he questioned whether light-based therapies could offer an effective solution for his patients. That uncertainty began to turn when he received treatment for his persistent rotator cuff injury. Finally able to sleep through the night without pain, Dr. Kelemen saw the value this service could offer to his patients.
Dr. Kelemen gradually introduced MLS Laser Therapy to his practice, starting with a small sample of patients with plantar fasciitis, Achilles tendonitis, and metatarsal bursitis. After validating the technology’s effectiveness, it quickly became a central pillar of his practice.
Over the years, Dr. Kelemen has treated more than 1,400 patients with MLS Laser Therapy, achieving an 85% success rate.
Building on these early successes, Dr. Kelemen quickly realized the technology’s potential could extend far beyond common foot and ankle conditions. This insight prompted him to explore its role in post-surgical recovery.
With post-operative MLS Laser Therapy sessions, patients experience faster and more comfortable recoveries with reduced pain and inflammation. Encouraged by these results, Dr. Kelemen was inspired to look beyond traditional indications in order to push the boundaries of what this device could do.
Diabetic patients presented one of the greatest opportunities to challenge this technology’s limitations. Prior to MLS Laser Therapy, Dr. Kelemen had limited options to manage pain and discomfort associated with diabetic neuropathy. With this technology, he was able to target neuropathic pain, alleviating burning, tingling, and discomfort. Ongoing maintenance programs extend these benefits, helping patients reclaim the quality of life they thought was lost.
Still curious about the possibilities of MLS Laser Therapy, he pushed further. Guided by emerging scientific literature, Dr. Kelemen applied laser therapy to the management of diabetic ulcer wounds. The results were striking. Healing times were cut in half, and many patients progressed more quickly into orthopedic shoes. These faster outcomes not only enhanced healing but also motivated patients to stay engaged in their care long-term.
While technology has advanced clinical outcomes, Dr. Kelemen emphasizes that true innovation comes from people. His wife and head laser technician, Cecile, has been pivotal in earning patient trust and ensuring compliance. Through clear communication, realistic expectations, and consistent follow-up, she has built an environment where patients feel supported and confident, fueling rapid growth through word-of-mouth referrals.
As his practice grows, Dr. Kelemen is excited to welcome his son, Brandon, to the practice after completing his residency, bringing both eagerness and a fresh perspective to the world of Podiatry. Through this experience, Dr. Kelemen has been reflecting on his own career to share his wealth of knowledge and offer advice to the next generation of physicians: stay open-minded, embrace innovation, and never be afraid to challenge the status quo.
For Dr. Kelemen, advanced therapies like the MLS Laser are more than just tools. They are “the way of the future” and a cornerstone he expects will remain central to his practice. Photobiomodulation marks a paradigm shift in medicine, but the journey of innovation is ongoing. With advanced technologies like MLS Laser Therapy, patients are experiencing consistently improved outcomes, setting a new standard of care.
